p21(WAF1/CIP1/SDI1) is elevated through a p53-independent pathway by mimosine

Cell Growth and Differentiation

Volumn 7, Issue 7, 1996, Pages 893-901

  Alpan, Recep S ^a   Pardee, Arthur B ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIMOSINE; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; MESSENGER RNA;

ARTICLE; CELL CYCLE G1 PHASE; COMPLEX FORMATION; DNA DAMAGE; DNA SYNTHESIS; EFFECTOR CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE INDUCTION; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; TARGET CELL; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; CELL CYCLE; DRUG EFFECT; FEMALE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; MIMOSINE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029657768     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 351: 453-456, 1991.
2. Sherr, C. J. G1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
3. Keyomarsi, K., and Pardee, A. B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA, 90: 1112-1116, 1993.
4. Murray, A. W., and Kirschner, M. W. Dominos and clocks: the union of two views of the cell cycle. Science (Washington DC), 246: 614-621, 1989.
5. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 57: 6304-6311, 1991.
6. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild type p53 is a cell cycle check point determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
7. Stewart, N., Hicks, G. G., Paraskevas, F., and Mowat, M. Evidence for a second cell cycle block at G2/M by p53. Oncogene, 10: 109-115, 1995.
8. Agarwal, M. L., Agarwal, A., Taylor, W., and Stark, G. R. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8493-8497, 1995.
9. EI-Deiry, W. S., Tokino, T., Valculescu, V. E., Levy, D. B., Pasons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
10. EI-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrel, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., and Vogelstein, B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
11. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. p53 dependent inhibition of cyclindependent kinase activities in human fibroblasts during radiation induced G1 arrest. Cell, 76: 1013-1023, 1994.
12. Michieli, P, Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994.
13. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53 dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev., 9: 935-944, 1995.
14. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olsen, E. N., Harper, J. W., and Elledge, S. J. p53 independent expression of p21/CIP1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
15. Johnson, M., Dimitrov, D., Vojta, P. J., Barrett, J. C., Noda, A., Pereira-Smith, O. M., and Smith, J. R. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/P21 RNA in human cells. Mol. Carcinog., 11: 59-64, 1994.
16. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
17. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1994.
18. Zhang, H., Hannon, G. J., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev., 8: 1750-1758, 1994.
19. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlact, B., Tsai, L., Zhang, P., Dobrowski, S., Bai, C., Connel-Crowley, L., Swindell, E., Fox, M. P., and Wei, N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell, 6: 387:400, 1995.
20. Sherr, C. J., and Roberts, J, M. Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev., 9: 1149-1163, 1995.
21. Lin, J. F., and Ling, K. H. Studies on free amino acids in the seeds of Leucaena glauca Benth: isolation and identification of mimosine. J. Formosan Med. Assoc., 60: 1-5, 1961.
22. Lalande, M. A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp. Cell Res., 186: 332-339, 1990.
23. Mosca, P. J., Dijkwel, P. A., and Hamlin, J. L. The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol. Cell. Biol., 12: 4375-4383, 1992.
24. Dai, Y., Gold, B., Vishwanatha, J. K., and Rhode, S. Mimosine inhibits viral DNA synthesis through ribonucleotide reductase. Virology, 205: 210-216, 1994.
25. Wang, Y., Zhao, J., Clapper, J., Martin, L. D., Du, C., DeVore, E. R., Harkins, K., Dobbs, D. L., and Benbow, R. M. Mimosine differentially inhibits DNA replication and cell cycle progression in somatic cells compared to embryonic cells of Xenopus laevis. Exp. Cell Res., 277: 84-91, 1995.
26. Gilbert, D. M., Neilson, A., Miyazawa, H., DePamphelis, M. L., and Burhans, W. C. Mimosine arrests DNA synthesis at replication forks by inhibiting deoxynucleotide metabolism. J. Biol. Chem., 270: 9597-9606, 1995.
27. Mosca, P. J., Lin, H. B., and Hamlin, J. L. Mimosine, a novel inhibitor of DNA replication, binds to a 50kDa protein in Chinese hamster cells. Nucleic Acids Res., 23: 261-268, 1995.
28. Lin, H., Falchetto, R., Mosca, P. J., Shabanowitz, J., Hunt, D. F., and Hamlin, J. Mimosine targets serine methyltransferase. J. Biol. Chem., 271: 2548-2556, 1996.
29. Park, M. H., Wolff, E. C., and Folk, J. E. Hypusine. Its post-translational formation in eucaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors, 4: 95-104, 1993.
30. Hanauske-Abel, H. M., Park, M. H., Hanauske, A. R., Popowitcz, A. M., Lalande, M., and Folk, J. E. Inhibition of the G1/S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochem Biophys. Acta, 7227: 115-124, 1994.
31. Liu, X. L., Band, H., Gao, Q., Wazer, D. E., Chu, Q., and Band, V. Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression. Carcinogenesis (Lond.), 15: 1969-1973, 1994.
32. Urbani, L., Sherwood, S. W., and Schimke, R. T. Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronization. Exp. Cell Res., 219: 159-168, 1995.
33. Jackson, P., Chevalier, S., Philippe, M., and Kirschner, M. W. Early events in DNA replication require cyclin E and are blocked by p21/CIP1. J. Cell Biol., 130: 755-769, 1995.
34. Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., Pagano, M. Human cyclin E: a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol., 15: 2612-2624, 1995.
35. Warbrick, E., Lane, D. P., Glover, D. M., and Cox, L. S. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21/WAF1 and proliferating cell nuclear antigen. Curr. Biol., 5: 275-282, 1995.
36. Dulic, V., Lees, E., and Reed, S. I. Association of human cyclin E with a periodic G1-S phase protein kinase. Science (Washington DC), 257: 1958-1961, 1992.
37. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J., and Leder, P. Mice lacking p21 undergo normal development, but are defective in G1 check point control. Cell, 82: 675-684, 1995.
38. Collins, A., and Oates, D. J. Hydroxyurea: effects on deoxyribonucleotkte pool sizes correlated with effects on DNA repair in mammalian cells. Eur. J. Biochem., 169: 299-305, 1987.
39. Ashman, C. R., Reddy, G. P. V., and Davidson, R. L. Bromodeoxyuridine mutagenesis, ribonucleotide reductase activity, and deoxyribonucleotide pools in hydroxyurea-resistant mutants. Somatic Cell Genet., 7: 751-768, 1981.
40. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
41. Russo, V. E. A., Brody, S., Cove, D., and Ottolenghi, S. Development: The Molecular Genetic Approach. Berlin: Springer-Verlag, 1992.
42. Stryer, L. Biochemistry, Ed. 3, pp. 610-612. New York: W. H. Freeman & Co., 1988.
43. Nyholm, S., Mann, G. J., Johansson, A. G., Bergeron, R. J., Graslund, A., and Thelander, L. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators. J. Biol. Chem., 268: 26200-26205, 1993.
44. Tsai, W. C., and Ling, K. H. Toxic action of mimosine. J. Formosan Med. Assoc., 71: 23-30, 1972.
45. Yoshioka, A., Tanaka, S., Hiraoko, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garret, C., and Wataya, Y. Deoxyribonucleoside triphosphate imbalance. J. Biol. Chem., 262: 8235-8241, 1987.
46. Jha, A. N., Hande, P. M., Mullenders, L. H. F., and Natarajan, A. T. Mimosine is a potent clastogen in primary and transformed hamster fibroblasts but not in primary or transformed human lymphocytes. Mutagenesis, 10: 385-391, 1995.
47. Skoog, L., and Nordenskjold, B. Effects of hydroxyurea and 1-β-oarabinofuranosyl-cytosine on deoxyribonucleotide pools in mouse embryo cells. Eur. J. Biochem., 19: 81-89, 1971.
48. Zhan, Q., EI-Deiry, W., Bae, I., Alamo, I., Kastan, M. B., Vogelstein, B., and Fornace, A. J., Jr. Similarity of the DNA-damage responsiveness and growth-suppressive properties of WAF1/CIP1 and GADD45. Int. J. Oncol., 6: 937-946, 1995.
49. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-560, 1995.
50. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., and Koff, A. p27KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
51. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., and Wang, X. F. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA, 92: 5545-5549, 1995.
52. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
53. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-813, 1994.
54. Fan, S., EI-Deiry, W., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J., Jr., Magrath, I., Kohn, K. W., and O'Connor, P. M.p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54: 5824-5830, 1994.
55. McGinn, C. J., Miller, E. M., Lindstrom, M. J., Kunugi, K. A., Johnston, P. G., and Kinsella, T. J. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization. Int. J. Radiat. Oncol. Biol. Phys., 30: 851-859, 1994.
56. Dobrowsky, W., Dobrowsky, E., and Rauth, A. M. Mode of interaction of 5-fluorouracil, radiation, and mitomycin C: in vitro studies. Int. J. Radiat. Oncol. Biol. Phys., 22: 875-880, 1992.
57. Withmore, G. F., Varghese, A. J., and Gulyas, S. Cell cycle responses of two X-ray mutants defective in DNA repair. Int. J. Radiat. Biol., 56: 657-665, 1989.
58. Band, V., Zajchowski, D., Swisshelm, K., Trask, D., Kulesa, V., Cohen, C., Conolly, J., and Sager, R. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res., 50: 7351-7357, 1990.
59. Ausubel, R., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., Struhl, K. Current Protocol in Molecular Biology. New York: Green Publishing Associates and Wiley-lnterscience, 1988.
60. Crissman, H. A., and Steinkamp, J. A. Rapid simultaneous measurement of DNA, protein and cell volume in single cells from large mammalian cell populations. J. Cell Biol., 59: 766-771, 1973.